Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AccrelistSGX:QZG +13.11% EV-to-FCF is 191.36 as of Aug. 18, 2026, which is 6614% above its 10-year median of 2.85. The stock has 6 warning signs investors should review. Among 409 Healthcare Providers & Services companies, Accrelist ranks worse than 94.62% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Accrelist's Enterprise Value is S$24.69 Mil.
Accrelist's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was S$0.13 Mil. Therefore, Accrelist's EV-to-FCF for today is 191.36.
The historical rank and industry rank for Accrelist's EV-to-FCF or its related term are showing as below:
SGX:QZG'
s EV-to-FCF Range Over the Past 10 Years
Min: -13.93 Med: 2.85 Max: 181.05
Current: 171.46
During the past 13 years, the highest EV-to-FCF of Accrelist was 181.05. The lowest was -13.93. And the median was 2.85.
SGX:QZG's EV-to-FCF is ranked worse than 94.62% of 409
companies
in the Healthcare Providers & Services industry
Industry Median: 18.66
vs SGX:QZG: 171.46
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Accrelist's share price for today is S$0.069.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Accrelist's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was S$-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Accrelist EV-to-FCF Related Terms
Accrelist EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Accrelist's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Accrelist's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accrelist EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Accrelist's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Accrelist's EV-to-FCF falls into.
Accrelist's current Enterprise Value is S$24.69 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Accrelist's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was S$0.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accrelist (SGX:QZG) has a EV-to-FCF of 191.36 as of Aug. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Accrelist and its competitors. This is 6614% above median its historical median of 2.85. According to the industry distribution chart, Accrelist ranks #387 out of 409 companies in the Healthcare Providers & Services industry, placing it in the top 94.6%.
Is Accrelist's EV-to-FCF too high?
Accrelist's current EV-to-FCF of 191.36 is 6614% above median its 10-year median of 2.85. The Healthcare Providers & Services industry median EV-to-FCF is 18.66. Accrelist's value of 191.36 is 925.5% above this industry median. Based on the distribution chart, Accrelist ranks #387 out of 409 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Accrelist's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Accrelist ranks #387 out of 409 companies for EV-to-FCF. This places Accrelist in the lower half of its industry. The industry median EV-to-FCF is 18.66. Accrelist's value of 191.36 is 925.5% above this benchmark. While the company's 10-year median is 2.85 vs. the industry median of 18.66, Accrelist has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.66, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accrelist's current EV-to-FCF of 191.36 is 925.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Accrelist and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accrelist's current EV-to-FCF is 191.36, which is 6614% above median its own 10-year median of 2.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accrelist stock overvalued right now?
Based on GuruFocus' analysis, Accrelist (SGX:QZG) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.04, compared to a current price of S$0.07 — trading 72.5% above its estimated fair value. The current EV-to-FCF is 191.36, which is 6614% above median its 10-year median of 2.85 and 925.5% above the Healthcare Providers & Services industry median of 18.66. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Accrelist (SGX:QZG), the current EV-to-FCF is 191.36 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:QZG has been successfully added to your 
